BioCentury
ARTICLE | Clinical News

Genentech regulatory update

March 7, 1994 8:00 AM UTC

Genentech Inc. (GNE) GNE (South San Francisco) received U.S. Patent No. 5,284,763, covering all forms of transforming growth factor beta (TGF-B) made by recombinant technology. The patent covers nucle...